Gurpreet Singh

Gurpreet Singh

Auto-generated profile, based on publicly available information

Gurpreet Singh

Delhi Univ, Army Hosp Res & Referral, New Delhi, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2021 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
PDF file
SKSoumya Krishnamoorthy
Soumya Krishnamoorthy
GSGurpreet Singh
Gurpreet Singh
JKJithu Jose K
Jithu Jose K
BSBiju Soman
Biju Soman
CFChristian Foerch
Christian Foerch
PSP.N. Sylaja
P.N. Sylaja
Background: Hemorrhagic transformation (HT) is a complication that occurs spontaneously or after thrombolysis in acute ischemic stroke (AIS) and can increase morbidity and mortality. The association of biomarkers with the risk of HT has been variably reported. We conducted a systematic review of the literature and meta-analysis and sought to compare blood biomarkers associated with HT and its subtypes by evaluating its predictability and correlation with outcome in AIS. Methods: The study protocol was registered in the PROSPERO database (CRD42020201334) and adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Among 2,230 articles identified from Cochrane Library, PubMed, and Web of Science databases, 30 quality-appraised articles were found eligible. Meta-analysis was conducted for matrix metalloproteinase-9 (MMP-9), cellular fibronectin (c-Fn), ferritin, S100 calcium-binding protein B (S100B), and neutrophil-lymphocyte ratio (NLR). We also reviewed biomarkers for correlation with the functional outcome at 90 days from stroke onset (poor outcome modified Rankin scale >2). Results: The pooled diagnostic odds ratio (DORpooled) was the highest for baseline c-Fn levels (299.253 [95% CI, 20.508–4,366.709]), followed by MMP-9 (DORpooled, 29.571 [95% CI 17.750–49.267]) and ferritin (DORpooled, 24.032 [95% CI 2.557–225.871]). However, wide confidence intervals for ferritin and c-Fn suggested lesser reliability of the markers. Patients with MMP-9 levels ≥140 ng/mL were 29.5 times at higher risk of developing symptomatic HT after AIS (area under the curve = 0.881). S100B (DORpooled, 6.286 [95% CI, 1.861–21.230]) and NLR (DORpooled, 5.036 [95% CI, 2.898–8.749]) had lower diagnostic accuracies. Among the markers not included for meta-analysis, caveolin-1, thrombin-activated fibrinolysis inhibitor, plasminogen activator inhibitor-1, and soluble ST2 were highly sensitive. Elevated levels of MMP-9, ferritin, and NLR were found to be associated with poor functional outcomes and mortality. Conclusion: Of the 5 biomarkers, there was enough evidence that MMP-9 has higher diagnostic accuracy for predicting the risk of HT before thrombolysis. MMP-9, ferritin, and NLR also predicted poor short-term outcomes.

1 July 2017 in Medical Journal Armed Forces India
Verified
Journal Article
Closed access
GSGurpreet Singh
Gurpreet Singh
SKS.K. Kaushik
S.K. Kaushik
SMS. Mukherji
S. Mukherji

1 January 2019 in Indian Journal of Public Health
Verified
Journal Article
Open access
PDF file
GSGurpreet Singh
Gurpreet Singh
RTRina Tilak
Rina Tilak
SKSk Kaushik
Sk Kaushik
Background: Major determinant of dengue incidence is interaction between ecology, vector bionomics, and social factors. Objectives: The objective of the study is to find out bio-eco-social determinants of Aedes breeding. Methods: Background, household, entomological, and knowledge, attitude, and practice (KAP) surveys were undertaken post- and premonsoon showers from May to June 2016 in urban and rural practice area of medical college. Results: A total of 181 and 204 households, 131 and 137 individuals, and 1250 and 1268 water-holding containers were included in household survey, KAP survey, and larval survey in urban slum and rural area, respectively. In both locations, maximum water-holding containers were indoors (41.4% and 61.8%, respectively); however, maximum positivity was peridomestic (63.6% and 83.1%, respectively). Pupae per container were 0.9 and 1.9 in respective locations and pupae per person were 1.2 and 2.3, respectively. Container positivity was seen in containers with rain as water source (8.8%) as well as among those who were never used (10.7%). Irregular water supply was significantly more in rural area (P < 0.05). KAP survey revealed that majority (90.1% and 71.5%, respectively) had heard about dengue, with significantly higher knowledge in urban slum, and television was the main source of information. Majority (89% and 83%, respectively) were unaware that peak biting time of Aedes is daytime. Use of mosquito repellent coils was the predominant preventive practice (46.6% and 61.2%, respectively). Pupae were reared; all were found to be Aedes aegypti. Conclusions: Despite enhanced awareness campaigns, an integrated vector management approach is required for prevention of dengue.

23 November 2024 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
MSManjit Singh
Manjit Singh
RKRatheesh Kumar
Ratheesh Kumar
VKVishal Kansal
Vishal Kansal
ASAnuj Singhal
Anuj Singhal
AKAmul Kapoor
Amul Kapoor
GSGurpreet Singh
Gurpreet Singh

16 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
GSGurpreet Singh
Gurpreet Singh
SPSeema Patrikar
Seema Patrikar
PSP Sankara Sarma
P Sankara Sarma
BSBiju Soman
Biju Soman
Introduction: Dynamic tools and methods to assess the ongoing transmission potential of COVID-19 in India are required. We aim to estimate time-dependent transmissibility of COVID-19 for India using a reproducible framework. Methods: Daily COVID-19 case incidence time series for India and its states was obtained from https://api.covid19india.org/ and pre-processed. Bayesian approach was adopted to quantify transmissibility at a given location and time, as indicated by the instantaneous reproduction number (R eff ). Analysis was carried out in R version 4.0.2 using “EpiEstim_2.2-3” package. Serial interval distribution was estimated using “uncertain_si” algorithm with inputs of mean, standard deviation, minimum and maximum of mean serial interval as 5.1, 1.2, 3.9 and 7.5 days respectively; and mean, standard deviation, minimum, and maximum of standard deviations of serial interval as 3.7, 0.9, 2.3, and 4.7 respectively with 100 simulations and moving average of seven days. Results: A total of 9,07,544 cumulative incident cases till July 13 th , 2020 were analysed. Daily COVID-19 incidence in the country was seen on the rise; however, transmissibility showed a decline from the initial phases of COVID-19 pandemic in India. The maximum R eff reached at the national level during the study period was 2.57 (sliding week ending April 4 th , 2020). R eff on July 13 th , 2020 for India was 1.16 with a range from 0.59 to 2.98 across various states/UTs. Conclusion: R eff provides critical feedback for assessment of transmissibility of COVID-19 and thus is a potential dynamic decision support tool for on-ground public health decision making.

1 April 2020 in Medical Journal Armed Forces India
Verified
Journal Article
Open access
GSGurpreet Singh
Gurpreet Singh
SPSeema Patrikar
Seema Patrikar
DBD.R. Basannar
D.R. Basannar
VBV.K. Bhatti
V.K. Bhatti
Evidence-based policy decision-making is introduction of newer technology that it is 'not inferior' to existing technology. Multiple randomised clinical trials (RCTs) on tuberculosis (TB) treatment have shown mixture of favourable, unfavourable and non-significant changes in outcomes with the use of fixed-dose combination (FDC) regimens. The aim of this study was to assess clinical effectiveness of FDC regimen as compared to the use of separate drugs in anti-TB treatment. Systematic literature search was carried out. RCTs with newly diagnosed smear-positive pulmonary TB cases were included. Defined outcomes were smear conversion, relapse, adverse reactions and patient compliance. Initial search revealed 457 articles, out of which 7 were included for meta-analysis. Pooled risk ratio for smear conversion rate at the end of intensive phase was 1.01 (95% confidence interval [CI], 0.99-1.03; p = 0.40). Similarly, smear conversion rate at the end of treatment showed no significant difference (relative risk (RR) = 1.01; 95% CI, 0.99-1.02; p = 0.45). Pooled risk ratio for combined smear conversion rates was 1.01 (95% CI, 0.99-1.02). However, relapse rates showed marginally higher trend with FDC regimens (RR, 1.56; 95% CI, 0.95-2.56; p = 0.49). Pooled analysis for adverse events showed no significant difference (RR = 0.98; 95% CI, 0.86-1.11; p = 0.70). Analysis of patient compliance showed marginal increase among FDC group (RR = 1.02; 95% CI, 0.96-1.09; p = 0.47)). Fixed-dose combination (FDC) formulations are not inferior in treatment outcomes. It may also ease programme managers and patients by improving compliance. However, increase in relapse rates needs further evaluation through large multicentric studies before implementing policy change in the national programme.